| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:GSK3335103
CAS:1893340-21-0
Package:50mg
|
|
| | GSK3335103 Basic information |
| Product Name: | GSK3335103 | | Synonyms: | GSK3335103;1-Pyrrolidinebutanoic acid, 3-fluoro-β-[3-(2-methoxyethoxy)phenyl]-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-, (βS,3S)- | | CAS: | 1893340-21-0 | | MF: | C27H36FN3O4 | | MW: | 485.59 | | EINECS: | | | Product Categories: | | | Mol File: | 1893340-21-0.mol |  |
| | GSK3335103 Chemical Properties |
| Boiling point | 687.132±55.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.252±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 4.274±0.10(predicted) |
| | GSK3335103 Usage And Synthesis |
| Uses | GSK3335103 is an orally active, non-peptide αvβ6 integrin inhibitor (pIC50=8). GSK3335103 can be used in the study of pulmonary fibrosis[1]. | | References | [1] Procopiou P A, et al. Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors[J]. Journal of Medicinal Chemistry, 2024. DOI:10.1021/acs.jmedchem.4c01430 |
| | GSK3335103 Preparation Products And Raw materials |
|